Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
Advances in Therapy|July 12, 2025
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 TrialYan Zhao, Litao Zhang, Liming Wu, et al.
Clinical and Translational Allergy|November 19, 2025
Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 TrialYan Zhao, Litao Zhang, Liming Wu, et al.
The Journal of Dermatological Treatment|July 6, 2026
Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trialYan Zhao, Litao Zhang, Liming Wu, et al.
The British Journal of Dermatology|November 29, 2025
Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trialDuoqin Wang, Jiyuan Wu, Qing Guo, et al.
Experimental Dermatology|June 19, 2026
Serum DSDNA is Associated With PsoriasisQi Zhen, Na Yin, Weiwei Chen, et al.
International Immunopharmacology|September 26, 2024
Serum dsDNA is environmentally contingentQi Zhen, Weiwei Chen, Yang Han, et al.
The Journal of Dermatological Treatment|July 15, 2026
Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trialsYan Zhao, Furen Zhang, Bin Yang, et al.
Genome Announcements|August 6, 2016
Draft Genome Sequence of Fonsecaea nubica Strain CBS 269.64, Causative Agent of Human ChromoblastomycosisFlávia F Costa, Sybren de Hoog, Roberto T Raittz, et al.
Genome Announcements|July 30, 2016
Draft Genome Sequence of Fonsecaea monophora Strain CBS 269.37, an Agent of Human ChromoblastomycosisAmanda Bombassaro, Sybren de Hoog, Vinicius A Weiss, et al.
Mycoses|June 2, 2024
Epidemiologic features and therapeutic strategies of kerion: A nationwide multicentre studyRuixin Deng, Xiaoqing Chen, Dongyan Zheng, et al.
Pageof 21